Gene: MCMDC2
Official Full Name: minichromosome maintenance domain containing 2provided by HGNC
Gene Summary: Predicted to enable ATP binding activity and DNA binding activity. Predicted to be involved in double-strand break repair via break-induced replication. Predicted to act upstream of or within meiosis I cell cycle process; oogenesis; and spermatogenesis. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16292 | MCMDC2 Knockout cell line (HEK293) | Human | MCMDC2 | 1:3~1:6 | Negative | Online Inquiry |
MCMDC2 Gene Knockout Cell Lines represent a pioneering resource in the realm of genetic research, specifically designed to facilitate in-depth studies of the MCMDC2 gene's function and its regulatory pathways. These cell lines are engineered to exhibit a complete knockout of the MCMDC2 gene, enabling researchers to investigate the consequences of its disruption on cellular processes such as proliferation, apoptosis, and differentiation.
The key mechanism underlying these cell lines lies in the precise manipulation of the genome through technologies such as CRISPR-Cas9 or homologous recombination, ensuring that the knockout is both effective and reproducible. By removing the MCMDC2 gene, researchers can elucidate its roles in cellular signaling and disease mechanisms, particularly in cancer biology and genomic stability studies.
The scientific importance of MCMDC2 Gene Knockout Cell Lines is multi-faceted, finding applications across various research domains including tumor biology, drug response studies, and genetic screening. These cell lines offer invaluable insights into how disruptions in the MCMDC2 gene may contribute to oncogenesis or render cells more susceptible to therapeutic agents, thus holding promise for targeted cancer therapies.
What sets these cell lines apart from alternatives is not only their enhanced specificity for the MCMDC2 gene but also their robust functionality in diverse cellular contexts. While traditional knockouts can produce off-target effects or lack the depth of characterization, our MCMDC2 Gene Knockout Cell Lines are rigorously validated, ensuring high confidence in experimental results.
For researchers and clinicians, the ability to reliably study the MCMDC2 gene in a controlled setting opens numerous avenues for innovation in treatment strategies and biomarker development. Harnessing these cell lines can significantly expedite research timelines and contribute to pioneering discoveries in gene function.
As a leader in the development of high-quality biological tools, our company is dedicated to providing researchers with the resources necessary to push the boundaries of scientific knowledge. Our commitment to innovation and excellence positions us as a trusted partner in advancing research and clinical applications in genetics and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.